drugset / Trial / NCT02831231
Pilot Study Comparing Effects of Xanomeline Alone to Xanomeline Plus Trospium
RandomizedParallel-groupTriple-blindTreatment
Summary
This study is intended to determine whether the addition of trospium chloride to xanomeline tartrate will ameliorate the peripheral cholinergic side effects that have been previously experienced with xanomeline tartrate when administered alone.
Timeline
- Start
- 2016-09-07
- Primary completion
- 2016-10-28
- Completion
- 2016-10-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Trospium | Small molecule | 20 mg | — |
| Subject | Xanomeline | Small molecule | 75 mg | — |